Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 14,912 | 10,220 | 13,916 | 13,722 | 11,470 |
| Operating Income | -14,912 | -10,220 | -13,916 | -13,722 | -11,470 |
| Other Income | 1,700 | 1,887 | 2,099 | 1,400 | 1,119 |
| Pre-tax Income | -13,212 | -8,333 | -11,817 | -12,322 | -10,351 |
| Income Tax | -20 | -17 | -15 | -21 | -11 |
| Net Income Continuous | -13,192 | -8,316 | -11,802 | -12,301 | -10,340 |
| Net Income | $-13,192 | $-8,316 | $-11,802 | $-12,301 | $-10,340 |
| EPS Basic Total Ops | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.09 | -0.05 | -0.08 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.09 | -0.05 | -0.08 | -0.09 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 |
| EBITDA(a) | $-14,878 | $-10,189 | $-13,878 | $-13,684 | $-11,433 |